Novartis India MD Milan Paleja to step downMilan Paleja has informed the company's board of his decision to resign as the vice chairman and managing director effective May 31, 2019.
05 Dec, 2018, 04.07 PM IST
Novartis India appoints Milan Paleja as vice chairman and MDPaleja is currently country president at Novartis in India and is also responsible for the pharmaceuticals business in the country. He is a...
10 May, 2018, 08.29 PM IST
Novartis India MD Jawed Zia resignsThe board, the filing said, has requested the nomination and remuneration committee to identify and recommend a suitable successor for the ...
17 Mar, 2018, 04.01 PM IST
Exchanging notes about parenthood! Radha Kapoor and Siddharth Shahani will be happy parents soonRadha Kapoor, daughter of Yes Bank founder Rana Kapoor and Siddharth Shahani, scion of Novartis India are over the moon.
28 Mar, 2017, 10.48 AM IST
High Court stops Cipla's generic drug salesSources said the court on Friday issued an interim injunction directing Cipla to stop the sale of the generic drug in the market.
10 Jan, 2015, 12.50 PM IST
GSK Consumer Healthcare Zubair Ahmed appointed head of Asia Pacific, Middle East and Africa regionAs part of the new role, Ahmed will oversee operations of over 100 countries, joining the growing league of Indians taking on top roles glo...
08 Oct, 2014, 12.34 PM IST
Novartis sales team involved in bribing stockists for over a yearStockists had complained that Novartis' sales representatives had been offering massive discounts in order to push sales.
17 Jun, 2013, 09.51 AM IST
Novartis fears it may lose Glivec case in Supreme CourtThe Supreme Court is slated to announce a verdict in the case filed by Novartis in 2006 against the Indian government, challenging a key pu...
28 Mar, 2013, 05.54 AM IST
Ranbaxy misses out on first-day launch of hypertension drug's generic versionThe company is yet to get the US food and Drug Administration's approval for the generic version of the drug, valsartan.
25 Sep, 2012, 06.54 AM IST
Protests in US over high pricing of Novartis' anti-cancer drug GlivecOver 300 petitioners have demanded that the Obama administration force Novartis to cut the price of Glivec, which they say is too high.
15 May, 2012, 11.32 AM IST
- China beats India in race to attract global pharma companies
In the past two years, cos such as GlaxoSmithkline, Novartis and Astra Zeneca have turned focus to China, promising investment worth billio...
26 Nov, 2011, 01.14 AM IST
- Novartis ties up with USV to market Galvus in India
Novartis has tied up with leading healthcare company - USV - to market its anti-diabetic product Galvus.
27 Nov, 2008, 01.04 AM IST
- Novartis launches programme to cover rural areas
Novartis India on Wednesday said it has launched Arogya Parivar, a programme, to address the health needs of rural areas, which would give ...
17 Sep, 2008, 09.09 PM IST
- After Chennai HC riposte, Novartis should introspect
Earlier this week, the Chennai High Court, in the Novartis case, observed that international treaties are akin to contracts, and where they...
10 Aug, 2007, 05.34 AM IST
- Novartis not to plead Glivec case
Novartis moves to Madras HC seeking removal of former patent chief from IPAB.
02 Aug, 2007, 03.27 AM IST
- IPAB hears Novartis’ objection against S Chandrasekaran
The Indian Patent Appellate Board (IPAB) on Monday heard a case that will decide whether S Chandrasekaran, former controller general of pat...
03 Jul, 2007, 04.16 AM IST
- Zelnorm copycats may go off the shelves
Generic versions of Novartis’ Zelnorm - a widely used drug to treat irritable bowel syndrome and constipation.
12 Jun, 2007, 01.27 AM IST